HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NGO Seeks FDA Guidance On Colorant Use In Feminine Cleansers

This article was originally published in The Rose Sheet

Executive Summary

Women's Voices for the Earth asks FDA to issue guidance regarding appropriate use of color additives in feminine personal-cleansing products following research indicating that certain colorants may pose health risks to women if the products are used as marketed.

You may also be interested in...



FDA Denies WVE Petition For Feminine Wash Colorant Guidance

FDA doesn’t see a need for the guidance requested by Women’s Voices for the Earth, but that doesn’t mean the NGO’s point was entirely lost on the agency. Feminine washes continue to contain colorants permitted for external use only – a seeming paradox, particularly in light of pH balance claims.

Congressional Appropriators Press FDA For Feminine Cleanser Guidance

Colorants approved exclusively for external use are central to concerns raised about feminine wash products by NGO Women’s Voices for the Earth and its ears in Congress. However, FDA’s ongoing review could explore the broader question of whether such items are properly classified and controlled.

Prestige Brands Extends Summer’s Eve Line On Ingredient Concerns

Summer’s Eve helped drive the firm’s net sales up 3% to $257m in Prestige Brand’s latest quarter, but it also drove analysts’ questions on whether the brand will sustain growth despite health care advocates’ concerns about potential harmful effects from some ingredients common in feminine wipe products.

Related Content

UsernamePublicRestriction

Register

RS019639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel